NL-OMON52679
Recruiting
Not Applicable
Mapping guided Stereotactic ablative Radiotherapy, Hybrid treatment for uncontrollable ventricular tachycardia - Mapping guided Stereotactic ablative Radiotherapy
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- eids Universitair Medisch Centrum
- Enrollment
- 12
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •In order to be eligible to participate in this study, a subject must meet all
- •of the following criteria:
- •\- Age \>\=18
- •\- Implanted ICD
- •\- Structural heart disease with myocardial scar
- •\- World Health Organization (WHO) / Eastern Cooperative Oncology Group (ECOG)
- •performance status grade 0\-3 in the past 3 months, or grade 4 if related to the
- •ar\-rhythmic presentation (from fully active to capable of limited self\-care,
- •see below for full explanation)
- •\- Presenting with at least one of the following
Exclusion Criteria
- •A potential subject who meets any of the following criteria will be excluded
- •from participation in this study:
- •\- Pregnancy
- •\- Interstitial pulmonary disease
- •\- Irreversible renal insufficiency with a glomerular filtration rate \<30ml/min
- •(not related to the high VT burden)
- •\- Life expectancy \<12 months in the absence of VT
- •\- Refusal or inability to provide informed consent or to undergo all
- •necessary evaluations, treatment and follow\-up for the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Mapping guided Stereotactic ablative RadiotherapyNL-OMON27436Departments of Cardiology and Radiotherapy, Leiden University Medical Center12
Completed
Phase 2
Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET): A Randomized Phase II Trialcancer spread to other parts of the bodymetastatic cancer10027476NL-OMON37922Vrije Universiteit Medisch Centrum20
Active, not recruiting
Phase 2
High dose Radiation therapy to eradicate early metastatic prostate cancer as an alternative to hormone or chemotherapy: a prospective phase II studyACTRN12618000566235Integrated Clinical Oncology Network Pty Ltd (ICON)208
Completed
Not Applicable
Stereotactic ablative radiotherapy (SABR) for small lung tumors: retrospective analysis 2009-2010C34C78.0Malignant neoplasm of bronchus and lungSecondary malignant neoplasm of lungDRKS00003864niversitätsklinikum Freiburg, Klinik für Strahlenheilkunde39
Active, not recruiting
Phase 2
MR-Guided Adaptive Stereotactic Body Radiotherapy (SBRT) of Primary Tumor for Pain Control in Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) – a Randomized, Controlled Clinical StudyC25Malignant neoplasm of pancreasDRKS00025801MU Klinikum10